FIRST Association Between the MUC 5 B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
暂无分享,去创建一个
I. Noth | D. Schwartz | N. Kaminski | K. Brown | M. Steele | T. Fingerlin | K. Gibson | T. Richards | Elissa Murphy | A. Peljto | J. Loyd | K. Kossen | S. Seiwert | Yingze Zhang | Janet L. Talbert | C. Markin | M. Schwarz | K. Lindell | M. Seibold | Anna L Peljto | Joe G. N. Garcia | L. Silveira | Shwu-Fan Ma
[1] A. Wells,et al. Acute Exacerbations of Idiopathic Pulmonary Fibrosis , 2013, Respiration.
[2] Brent S. Pedersen,et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis , 2013, Nature Genetics.
[3] A. Nicholson,et al. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis , 2013, Thorax.
[4] N. Kaminski,et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. , 2012, American journal of respiratory and critical care medicine.
[5] G. Raghu. Idiopathic pulmonary fibrosis: new evidence and an improved standard of care in 2012 , 2012, The Lancet.
[6] Joyce S Lee,et al. A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis , 2012, Annals of Internal Medicine.
[7] S. Sahn,et al. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. , 2011, American journal of respiratory and critical care medicine.
[8] Ivana V. Yang,et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. , 2011, The New England journal of medicine.
[9] I. Noth,et al. A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. , 2011, The New England journal of medicine.
[10] A. Nicholson,et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis , 2009, European Respiratory Journal.
[11] S. Sahn,et al. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial , 2009, The Lancet.
[12] M. Olschewski,et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.
[13] K. Boon,et al. Molecular Phenotypes Distinguish Patients with Relatively Stable from Progressive Idiopathic Pulmonary Fibrosis (IPF) , 2009, PloS one.
[14] N. Grishin,et al. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. , 2009, American journal of human genetics.
[15] F. Sciurba,et al. MMP 1 and MMP 7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis , 2008 .
[16] N. Kaminski,et al. Accelerated Variant of Idiopathic Pulmonary Fibrosis: Clinical Behavior and Gene Expression Pattern , 2007, PloS one.
[17] P. Lansdorp,et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.
[18] F. Martinez,et al. The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis , 2005, Annals of Internal Medicine.
[19] Jacqueline K. Wittke-Thompson,et al. Rational inferences about departures from Hardy-Weinberg equilibrium. , 2005, American journal of human genetics.
[20] P. Heagerty,et al. Survival Model Predictive Accuracy and ROC Curves , 2005, Biometrics.
[21] H. Collard,et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.
[22] F. Martinez,et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. , 2003, American journal of respiratory and critical care medicine.
[23] A. Nicholson,et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. , 2003, American journal of respiratory and critical care medicine.
[24] J. Tooze,et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. , 2001, American journal of respiratory and critical care medicine.
[25] G. Hunninghake,et al. Idiopathic pulmonary fibrosis. , 2001, The New England journal of medicine.
[26] F. Askin,et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. , 2001, The New England journal of medicine.
[27] S. Abe,et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. , 2000, American journal of respiratory and critical care medicine.